Search results for

Dr. Peter Hotez is part of a team working to develop a low-cost COVID vaccine that could be distributed globally. "Vaccines are coming," he says. "We have to get everybody through to the other side."

No vaccine is 100% effective. Though so-called "breakthrough" COVID cases are rare, the virus is circulating widely. What's a vaccinated person to do? And ... not do?

Drugs that can help keep COVID-19 patients out of the hospital are playing only a small role in Michigan, where the pandemic is accelerating. Logistical challenges are to blame.

Watch an expert panel discussion on the effort to develop and deploy safe and effective vaccines against COVID-19 on Friday, Nov. 20, to be live-streamed here at 12 p.m. ET

UC San Diego neuroscientist talks about his influences and creating brains in a dish

A KPBS analysis of city records revealed an epidemic of broken bins — residents ordered nearly 17,500 replacement bins in 2018 alone. And over the last decade, the number replaced annually has increased by 42%.

Using molecular dating tools and epidemiological simulations, researchers at UCSD estimate that the SARS-CoV-2 virus was likely circulating undetected for at most two months before the first human cases of COVID-19.

Airs Wednesdays, Sept. 9 - 30, 2020 at 10 p.m. on KPBS TV+ Sundays, Sept. 13 - Oct. 4 at 10 p.m. on KPBS 2 + PBS Video App

The drug company says the problem involved one batch of a substance that goes into its coronavirus vaccine. But the contractor, Emergent BioSolutions, has a history of problems.

Usually in U.S. health emergencies — HIV, vaping and more — the Centers for Disease Control and Prevention is key to shaping policy and explaining it. That's changing to our detriment, leaders say.